XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
OPERATING CASH FLOW    
Net earnings $ 1,499 $ 219
Adjustments to reconcile net earnings to operating cash flow:    
Equity method earnings, net of taxes (1,964) 0
Depreciation and amortization 52 53
Gain on sales of assets (8) (12)
Stock-based compensation 24 26
Deferred taxes (59) 26
Changes in assets and liabilities 450 194
Other (15) (5)
Operating cash flow (21) 501
INVESTING CASH FLOW    
Proceeds from the sale of NuScale shares 414 0
Purchases of marketable securities (88) (140)
Proceeds from sales and maturities of marketable securities 168 118
Capital expenditures (38) (133)
Proceeds from sales of assets 63 69
Investments in partnerships and joint ventures (203) (66)
Other 0 23
Investing cash flow 316 (129)
FINANCING CASH FLOW    
Repurchase of common stock (365) 0
Purchase and retirement of debt (37) (44)
Distributions paid to NCI (43) (8)
Capital contributions by NCI 65 0
Proceeds from NuScale share issuance (net of issuance fees) 0 80
Other (8) (6)
Financing cash flow (388) 22
Effect of exchange rate changes on cash 40 (1)
Increase (decrease) in cash and cash equivalents (53) 393
Cash and cash equivalents at beginning of period 2,829 2,519
Cash and cash equivalents at end of period 2,776 2,912
SUPPLEMENTAL INFORMATION:    
Cash paid for interest 35 41
Cash paid for income taxes (net of refunds) $ 124 $ (42)